| INDUSTRY NEWS | Scripps Institutions Join National Tumor Consortium The Scripps Research Institute, Scripps Health, and Scripps Translational Science Institute have announced they have joined a national consortium of research institutions headed by The Jackson Laboratory that is building a library of primary human tumors with the goal of developing highly targeted cancer therapies. [Scripps Research Press Release] Halozyme’s Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps Halozyme Therapeutics, Inc. announced final results from a study in type 1 diabetes patients who receive their insulin treatment with a pump demonstrating that Aspart-PH20, a formulation of Halozyme’s recombinant human hyaluronidase with the active ingredient in NovoLog®, reduces the variability of insulin absorption and reduces post-meal glycemic excursions compared to NovoLog alone. [Halozyme Therapeutics Inc., Press Release] |
|
|
|